Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Asper Biotech's Reprogenetic Tests

Premium

Asper Biotech recently launched several new reprogenetic tests. The Tartu, Estonia-based firm uses arrayed primer extension to test fetal cells for specific genetic abnormalities.

New assays as a service from its lab include its carrier test, which enables users to determine the carrier status of 92 mutations linked to 19 disorders, including sickle-cell anemia, beta-thalassemia, Tay-Sachs disease, and others.

The company also offers array-based testing for mutations associated with congenital adrenal hyperplasia, Noonan syndrome, skeletal dysplasia, and Smith-Lemli-Opitz syndrome.

BioArray News spoke with executives from Asper in September about the firm's reprogenetics offerings (BAN 9/13/2011).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.